BioCina Expands Partnership with GPN Vaccines Adelaide, South Australia, November 6, 2023, BioCina Pty Ltd., a global end-to-end biologics contract development and manufacturing organization (CDMO), announced…
GenomeFrontier Selects BioCina to Manufacture Minicircle and Plasmid DNA for Their CAR-T Cell Therapy Product ADELAIDE, Australia, Oct. 17, 2023 /PRNewswire/ — BioCina Pty Ltd., a global end-to-end biologics contract development and manufacturing organization (CDMO),…
UWA and Bridgewest Perth Pharma announce new partnership A new partnership between The University of Western Australia and BioCina and LumaCina will benefit the Western Australian biomedical and…
BioCina awarded Grants to develop enabling technologies for manufacture of precision mRNA vaccines MIAMI and ADELAIDE, Australia, April 27, 2023 /PRNewswire/ — BioCina, a leading contract development and manufacturing organization (CDMO) is pleased…
GPN Vaccines Case Study A case study highlighting how BioCina’s speed and proven track record in overcoming development and manufacturing challenges made them the…
BioCina announces opening of new GMP plasmid DNA manufacturing suite (SAN DIEGO and ADELAIDE June 13, 2022) BioCina, a leading contract development and manufacturing organization (CDMO) today announced that the…
BioCina awarded Grant to advance RNA vaccines and therapeutics (SAN DIEGO and ADELAIDE April 5, 2022) BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce…
Rick Hancock named as Board Chairman for BioCina (SAN DIEGO and ADELAIDE January 26,2022) BioCina, a leading contract development and manufacturing organization (CDMO) announces the appointment of Rick…
BioCina officially opens full-service CDMO in Adelaide, Australia, including mRNA and pDNA GMP manufacturing (SAN DIEGO and ADELAIDE, November 30, 2021) BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development…